Runben Biotechnology (SH:603193) Zheng Quan Zhi Xing·2025-05-15 11:14Group 1 - The core viewpoint of the article is that the legal opinions regarding the 2024 annual shareholders' meeting of Runben Biotechnology Co., Ltd. confirm that the meeting's procedures, participant qualifications, and voting results comply with relevant laws and regulations [1][8]. Group 2 - The shareholders' meeting is scheduled for May 15, 2025, at 15:00 in Guangzhou, and was convened by the company's board of directors based on a prior board meeting decision [2][3]. - A total of 7 shareholders and their representatives attended the meeting, holding shares registered as of May 9, 2025 [3]. - The meeting allowed for both on-site and online voting, with specific timeframes for each voting method clearly communicated to shareholders [4][5]. Group 3 - The online voting involved 80 shareholders representing 24,125,909 shares, accounting for 5.9630% of the company's total share capital [5]. - The voting results from both on-site and online methods were combined, and the meeting's resolutions were signed by the attending board members [8]. Group 4 - The legal opinions affirm that the meeting's convening, participant qualifications, voting procedures, and results are all valid and comply with the company's articles of association and applicable laws [6][8].